scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0021-9150(02)00150-8 |
P698 | PubMed publication ID | 12618269 |
P50 | author | Hugo ten Cate | Q37384164 |
Eric C. M. van Gorp | Q88002275 | ||
P2093 | author name string | Harry R Büller | |
Vincent I H Kwa | |||
Eric de Groot | |||
Dees P M Brandjes | |||
Victor E A Gerdes | |||
Roel P Verkooyen | |||
P2860 | cites work | Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide | Q28332888 |
Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp | Q28334980 | ||
Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae. | Q33758389 | ||
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
Infections, inflammation, and the risk of coronary heart disease | Q33887538 | ||
Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project | Q34457169 | ||
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis | Q37346172 | ||
Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study | Q37876040 | ||
Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease | Q37877190 | ||
Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. | Q37877681 | ||
Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden | Q37877684 | ||
Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis | Q37877895 | ||
Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study | Q37878104 | ||
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study | Q37878617 | ||
Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis | Q37880332 | ||
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 | ||
Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery | Q37881215 | ||
Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. | Q37881308 | ||
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA. | Q37881958 | ||
Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile | Q37881987 | ||
Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery | Q37882074 | ||
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
Chlamydia pneumoniae and acute myocardial infarction in Jerusalem | Q37882349 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
: Risk factors for seropositivity and association with coronary heart disease | Q37887420 | ||
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 | ||
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images | Q46735534 | ||
Variance components analysis of carotid and femoral intima-media thickness measurements. REGRESS Study Group, Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. | Q52905279 | ||
B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS) | Q74648364 | ||
P433 | issue | 1 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 65-71 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | Atherosclerosis | Q4813570 |
P1476 | title | Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis | |
P478 | volume | 167 |
Q26859186 | Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis |
Q37862624 | Chronic peripheral arteriopathy is associated with seropositivity to Chlamydia pneumoniae |
Q37866854 | Heat-inactivated C. pneumoniae organisms are not atherogenic. |
Q37866100 | Relationship between the peripheral arterial occlusive disease and the infection by Chlamydophila pneumoniae |
Search more.